Chronic Lung Disease of Prematurity Completed Phase 2 Trials for Montelukast (DB00471)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01717625The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary DysplasiaPrevention